Lastly, we found a marginally significant (p = 0.0590) increase in GFAP+ area fraction and a significant increase in CD68+ area fraction in high ADNC burden versus not AD/low ADNC burden donors, with intermediate ADNC burden donors exhibiting intermediate levels of reactive gliosis. This evidence concerns the gene GFAP and Alzheimer disease.